News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,153 Results
Type
Article (41069)
Company Profile (258)
Press Release (663826)
Section
Business (205712)
Career Advice (2061)
Deals (35611)
Drug Delivery (96)
Drug Development (82009)
Employer Resources (172)
FDA (16444)
Job Trends (15006)
News (348524)
Policy (33153)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2615)
Accelerated approval (5)
Adcomms (22)
Allergies (81)
Alliances (49966)
ALS (84)
Alzheimer's disease (1374)
Antibody-drug conjugate (ADC) (116)
Approvals (16444)
Artificial intelligence (242)
Autoimmune disease (17)
Automation (14)
Bankruptcy (361)
Best Places to Work (11775)
BIOSECURE Act (18)
Biosimilars (105)
Biotechnology (182)
Bladder cancer (62)
Brain cancer (28)
Breast cancer (260)
Cancer (2069)
Cardiovascular disease (167)
Career advice (1721)
Career pathing (29)
CAR-T (145)
Cell therapy (407)
Cervical cancer (19)
Clinical research (66556)
Collaboration (785)
Compensation (482)
Complete response letters (20)
COVID-19 (2620)
CRISPR (37)
C-suite (217)
Cystic fibrosis (100)
Data (2015)
Decentralized trials (2)
Denatured (17)
Depression (40)
Diabetes (251)
Diagnostics (6456)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (116)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (86)
Earnings (86594)
Editorial (32)
Employer branding (21)
Employer resources (146)
Events (112923)
Executive appointments (670)
FDA (17591)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (704)
Gene editing (100)
Generative AI (21)
Gene therapy (289)
GLP-1 (701)
Government (4467)
Grass and pollen (4)
Guidances (49)
Healthcare (19136)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (109)
Indications (27)
Infectious disease (2759)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (88)
Interviews (328)
IPO (16548)
IRA (40)
Job creations (3652)
Job search strategy (1459)
Kidney cancer (9)
Labor market (34)
Layoffs (458)
Leadership (16)
Legal (7977)
Liver cancer (72)
Lung cancer (302)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (277)
MASH (63)
Medical device (13564)
Medtech (13569)
Mergers & acquisitions (19556)
Metabolic disorders (647)
Multiple sclerosis (72)
NASH (17)
Neurodegenerative disease (83)
Neuropsychiatric disorders (24)
Neuroscience (1870)
NextGen: Class of 2025 (6622)
Non-profit (4537)
Northern California (2474)
Now hiring (37)
Obesity (349)
Opinion (210)
Ovarian cancer (74)
Pain (78)
Pancreatic cancer (78)
Parkinson's disease (143)
Partnered (20)
Patents (209)
Patient recruitment (98)
Peanut (46)
People (57596)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase I (20670)
Phase II (29294)
Phase III (21890)
Pipeline (1077)
Podcasts (46)
Policy (115)
Postmarket research (2624)
Preclinical (8731)
Press Release (66)
Prostate cancer (96)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (369)
Real estate (5971)
Recruiting (65)
Regulatory (22696)
Reports (46)
Research institute (2381)
Resumes & cover letters (353)
Rett syndrome (4)
RNA editing (4)
RSV (40)
Schizophrenia (65)
Series A (125)
Series B (80)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2148)
Special edition (14)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3606)
State (2)
Stomach cancer (15)
Supply chain (62)
Tariffs (12)
The Weekly (27)
United States (21664)
Vaccines (671)
Venture capitalists (37)
Webinars (12)
Weight loss (229)
Women's health (33)
Worklife (15)
Date
Today (89)
Last 7 days (509)
Last 30 days (2595)
Last 365 days (33595)
2025 (8547)
2024 (35600)
2023 (40479)
2022 (51579)
2021 (56116)
2020 (54607)
2019 (47270)
2018 (35586)
2017 (32572)
2016 (31982)
2015 (38003)
2014 (31693)
2013 (26729)
2012 (28994)
2011 (29704)
2010 (27770)
Location
Africa (735)
Alabama (50)
Alaska (7)
Arizona (228)
Arkansas (13)
Asia (38374)
Australia (6301)
California (5648)
Canada (1898)
China (480)
Colorado (249)
Connecticut (260)
Delaware (130)
Europe (83331)
Florida (841)
Georgia (197)
Idaho (57)
Illinois (506)
India (25)
Indiana (297)
Iowa (9)
Japan (145)
Kansas (101)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (848)
Massachusetts (4278)
Michigan (213)
Minnesota (379)
Mississippi (2)
Missouri (78)
Montana (28)
Nebraska (25)
Nevada (58)
New Hampshire (64)
New Jersey (1619)
New Mexico (29)
New York (1631)
North Carolina (943)
North Dakota (8)
Northern California (2474)
Ohio (195)
Oklahoma (15)
Oregon (33)
Pennsylvania (1274)
Puerto Rico (9)
Rhode Island (29)
South America (1109)
South Carolina (18)
South Dakota (1)
Southern California (2148)
Tennessee (95)
Texas (843)
Utah (168)
Virginia (133)
Washington D.C. (59)
Washington State (526)
West Virginia (3)
Wisconsin (49)
705,153 Results for "standard bariatrics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
BMS, Pfizer Challenge Colorectal Cancer Standard Care With ASCO GI Readouts
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that could position them as new standards of care in certain subtypes of metastatic colorectal cancer.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards
December 16, 2024
·
2 min read
Press Releases
Pharma Logistics, LLC and Rx Reverse Distributors, Inc. Unite, Setting a New Standard in Pharmaceutical Reverse Distribution
January 6, 2025
·
3 min read
Deals
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 20, 2024
Standard BioTools Inc. today announced that the Human Capital Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of May 20, 2024, under the Standard BioTools Inc. 2022 Inducement Equity Incentive Plan (Plan).
May 20, 2024
·
2 min read
Press Releases
Standard BioTools to Participate in Upcoming March 2025 Investor Conferences
February 28, 2025
·
1 min read
Biotech Bay
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Inc. (“Standard BioTools”) (Nasdaq:LAB) today announced that its management team will participate in the following investor conferences in the month of June.
May 22, 2024
·
2 min read
Policy
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Oragenics, Inc., a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced that it received a notice from the NYSE American LLC dated April 18, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards.
April 19, 2024
·
4 min read
Press Releases
Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis
March 10, 2025
·
15 min read
Press Releases
Alberta sets a new standard for advanced prostate cancer treatment with public reimbursement of Pluvicto™
March 10, 2025
·
4 min read
Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) Announces Launch to Set New Standard in Life Sciences Commercialization Management Consulting
Strategic Advisory for Leading Therapeutics Innovation Inc. (SALTI) is proud to announce its official launch, poised to set a new standard in life sciences consulting.
April 30, 2024
·
3 min read
1 of 70,516
Next
